Alliance Pharma (GB:APH) has released an update.
Alliance Pharma PLC has reported a change in major holdings following a transaction by Van Lanschot Kempen Investment Management NV, which resulted in a decrease in their voting rights from 5.0888% to 4.8275%, now holding a total of 26,088,068 voting rights as of June 12, 2024. The notification, completed on June 13, 2024, in Amsterdam, indicates a significant shift in stakeholder influence within the UK-based pharmaceutical company.
For further insights into GB:APH stock, check out TipRanks’ Stock Analysis page.
